N. Shahri

The effect of the oral PKC β inhibitor ruboxistaurin on vision loss in two phase 3 studies.

Matthew D. Davis, L. Aiello, J. Cunha-Vaz, 2013, Investigative ophthalmology & visual science.

ORAL PROTEIN KINASE C b INHIBITION USING RUBOXISTAURIN

Matthew D. Davis, L. Aiello, R. Milton, 2011 .

AB0492 Evaluation of Potential Drug-Drug Interactions with Baricitinib

W. Williams, E. Cannady, N. Shahri, 2015 .

Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib

Maria M. Posada, Stephen D. Hall, K. Hillgren, 2017, Clinical and translational science.

Effect of ruboxistaurin on albuminuria and estimated GFR in people with diabetic peripheral neuropathy: results from a randomized trial.

J. McGill, K. Tuttle, P. W. Anderson, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

EFFECT OF RUBOXISTAURIN (RBX) ON VISUAL ACUITY DECLINE OVER A 6-YEAR PERIOD WITH CESSATION AND REINSTITUTION OF THERAPY: Results of an Open-Label Extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2)

L. Aiello, R. Danis, K. Kles, 2011, Retina.

Longer Treatment Duration With Ruboxistaurin (RBX) Is Associated With Less Visual Acuity Decline Over a 6-Year Period Despite Cessation and Reinstitution of Therapy - Results of an Open-Label Extension of the Protein Kinase C-Diabetic Retinopathy Study 2 (PKC-DRS2)

L. Aiello, M. Davis, R. Danis, 2009 .